Latest News

‘Bane of my existence:’ The burden of Medicare Advantage denials


 

Time for action

Weighing in on the OIG report, Robert E. Wailes, MD, president of the California Medical Association, noted that “it has become common practice for health insurance companies to create obstacles for patients in hopes of not having to pay for essential healthcare.”

The reason for these obstacles is simple, he said: “Fewer procedures performed translates to larger insurance company profits.”

America’s Health Insurance Plans (AHIP) defended prior authorization, saying it is “an important patient safety, cost-saving, and waste-prevention tool.”

The group also called out the OIG review for its “extraordinarily small” sample of 247 prior authorization requests over 1 week.

“Drawing far-reaching conclusions based on a very small sample of data and misleading headlines is not a productive way to improve our healthcare system for patients,” the AHIP statement reads.

But, according to Anna Schwamlein Howard, who works on policy development at the American Cancer Society Cancer Action Network, the recent OIG report is in line with previous OIG reports.

And, Ms. Howard emphasized, the current report and others like it “highlight the need for CMS to utilize its audit authority and ensure that beneficiaries have access to medically necessary treatments, particularly cancer treatments.”

Along those lines, the OIG report recommends that the CMS should issue new guidance on the appropriate use of MAO clinical criteria in medical necessity reviews, update its audit protocols to address issues identified in the report, and direct MAOs to take additional steps to identify and address vulnerabilities that can lead to manual review and system errors.

In a statement, the CMS said it is committed to oversight and enforcement of the requirements of the Medicare Advantage program and agreed with the OIG recommendations.

“Lawmakers must act now to place patient needs before corporate profits and simplify by streamlining prior authorization processes,” Dr. Wailes said.

The ACS recently released a paper on this topic entitled, “The Medicare Appeals Process: Reforms Needed to Ensure Beneficiary Access.”

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

New York NPs join half of states with full practice authority
MDedge Hematology and Oncology
Med school to pay $1.2 million to students in refunds and debt cancellation in FTC settlement
MDedge Hematology and Oncology
Are free lunches back? Docs start seeing drug reps again
MDedge Hematology and Oncology
Cancer hospitals often mark up drug prices, ignore price transparency rules
MDedge Hematology and Oncology
Three in four U.S. doctors are employed by hospitals, corporate entities: Report
MDedge Hematology and Oncology
30 years of fake nursing ends with 7-year prison sentence
MDedge Hematology and Oncology
How old is too old to work as a doctor?
MDedge Hematology and Oncology
Docs find new and better ways to cut EHR documentation time
MDedge Hematology and Oncology
‘Together, we can demand improvements’: Stanford Health Care’s residents vote to join union
MDedge Hematology and Oncology
Innocent doc sued after 'secret' medical expert says claim has merit
MDedge Hematology and Oncology